Tarun Kumar Upadhyay | Biotechnology | Best Researcher Award

Published on by Cell Biologist

Dr. Tarun Kumar Upadhyay | Biotechnology | Best Researcher Award

Dr. Tarun Kumar Upadhyay  , Parul University , India

Dr. Tarun Kumar Upadhyay is an Associate Professor in the Department of Biotechnology at Parul University, Vadodara, Gujarat, India. He is an accomplished researcher with expertise in natural polymeric drug delivery systems, infectious diseases, and immunobiochemistry. Dr. Upadhyay has contributed significantly to the development of microparticulate formulations for drug targeting and is actively engaged in cutting-edge research on tuberculosis, cancer therapeutics, and immunology. He is a prolific author with numerous publications in prestigious journals, an invited reviewer for various scientific bodies, and a key figure in the academic community, supervising multiple Ph.D. candidates. Dr. Upadhyay’s broad skill set includes bioinformatics, molecular dynamics, and in silico drug design. He has received various awards and honors for his outstanding research contributions.

Publication Profile:

Orcid

Strengths for the Award:

  1. Extensive Academic and Research Background: Dr. Upadhyay holds a Ph.D. in Biotechnology, along with various degrees in Biotechnology, Bioinformatics, and related fields. His academic qualifications, including a post-graduate diploma in Bioinformatics, demonstrate his diverse and robust foundation in scientific research.
  2. Rich Teaching and Mentorship Experience: As an Assistant Professor and Scientist at Parul University, Dr. Upadhyay has extensive teaching experience at both undergraduate and postgraduate levels, guiding numerous students through their dissertations, including 18 MSc students and 4 Ph.D. students. His involvement in mentoring Ph.D. scholars and his leadership in the Research Advisory Committee underscore his dedication to nurturing the next generation of scientists.
  3. Outstanding Research Contributions: His research spans multiple facets of biotechnology, including drug delivery, infectious diseases, cancer biology, plant biotechnology, and immunology. With over 40 publications in reputable journals (such as Biomolecules, Agronomy, Molecules, and Antibiotics), he has made significant contributions to understanding complex biological mechanisms, including:
    • Targeted drug delivery using natural polymers (β-glucan microparticles).
    • Anticancer and antimicrobial properties of plant-derived compounds.
    • Immunomodulatory effects of novel therapeutic molecules.

    His work is often published in high-impact journals, with a high citation index (H-index: 17, i10-index: 34, 1169 citations on Google Scholar), showcasing the influence of his research in the scientific community.

  4. Recognition and Awards: Dr. Upadhyay has earned multiple accolades, such as the Best Biotechnologist Award (2020), Young Scientist Award (2020), and Faculty Research Excellence Award (2021) from Parul University, Vadodara. His recognition reflects his substantial impact in the field of biotechnology and life sciences.
  5. International Collaboration and Funded Projects: He has successfully led and contributed to several funded research projects, both independently and in collaboration with national and international institutions. These projects have included studies on antimicrobial and anticancer activities of bioactive molecules derived from fungi and plants, as well as immunomodulatory research related to infectious diseases such as tuberculosis.
  6. Editorial and Peer Review Responsibilities: Dr. Upadhyay’s active involvement in the editorial process and as a reviewer for prestigious journals further highlights his commitment to advancing scientific research. His membership in multiple scientific societies, such as the Indian Society of Cell Biology and International Society for Infectious Diseases, demonstrates his global scientific footprint.
  7. Leadership in Research Infrastructure: As the Member Secretary of the Institutional Biosafety Committee (IBKP) at Parul University and his work with biotech infrastructure, he has contributed significantly to shaping safe and ethical research practices in India.

Areas for Improvement:

  1. Broadening the Scope of Collaborations: While Dr. Upadhyay’s research has spanned various fields, there is room to expand his international collaborations further, particularly with research groups in the US, Europe, and other leading biotech hubs. This could enhance the global visibility of his research.
  2. Engagement in Public Outreach and Science Communication: Although Dr. Upadhyay has been recognized for his academic and research excellence, there is potential for greater involvement in science communication, such as participating in public science outreach programs, seminars, and workshops aimed at making complex scientific findings accessible to the public.
  3. Diversification of Research Areas: Dr. Upadhyay’s work has been primarily focused on certain key themes (e.g., drug delivery, cancer, infectious diseases). Exploring newer interdisciplinary areas like artificial intelligence in drug design, genomics, or precision medicine could further broaden his research portfolio.

Education:

Dr. Upadhyay completed his Ph.D. in Biotechnology from Integral University, Lucknow, India, where his thesis focused on yeast cell wall-derived β-glucan microparticles for anti-TB drug delivery. He also holds an M.Sc. and B.Sc. in Biotechnology, both with honors, from Integral University. Additionally, he has a Post Graduate Diploma in Bioinformatics from NIELIT (Jadavpur University). His academic foundation is complemented by extensive training in bioinformatics, molecular biology, and computational biology, enabling him to conduct innovative research in the areas of drug delivery systems, infectious diseases, and bioinformatics.

Experience:

Dr. Upadhyay has diverse academic and industrial experience spanning over a decade. He has worked as a Quality Control Chemist at Patanjali Ayurved Ltd and has been involved in R&D projects related to drug delivery systems. He has served as a Senior Research Assistant in a Government of UP-funded project on anti-TB drug delivery. In academia, he has held teaching positions at various institutions, including Suresh Gyan Vihar University and Parul University. At Parul University, he is currently supervising multiple Ph.D. students and leading research in the areas of drug delivery, immunology, and cancer research. He is also a member of several academic and research committees.

Awards and Honors:

Dr. Upadhyay has received numerous prestigious awards, including the Best Biotechnologist Award (2020), Young Scientist Award (2020), Associate Scientist Award (2021), and Faculty Research Excellence Award (2021) from Parul University. He was also honored with the Overall Best Research Performer Award (2022) and Highest Impact Factor Publication Award (2022) by Parul University. His research contributions have been recognized internationally, and he has been appointed as a Bentham Science Ambassador for 2022-2023. These accolades reflect his commitment to scientific excellence and his leadership in biotechnology research.

Research Focus:

Dr. Upadhyay’s research is focused on developing natural polymer-based drug delivery systems, specifically for infectious diseases such as tuberculosis and cancer. His studies explore the immunological aspects of drug delivery and the use of β-glucan microparticles in targeted therapy. He is also involved in the study of plant-based bioactive molecules, antimicrobial agents, and their therapeutic potential in oncology. His work in bioinformatics includes molecular dynamics, drug design, and prediction of ADMET properties. Dr. Upadhyay aims to advance the therapeutic application of biopolymers and bioactive compounds to improve treatment outcomes in various diseases.

Publication Top Notes:

  1. Terpenoid-Mediated Targeting of STAT3 Signaling in Cancer
  2. Elicitor-Mediated Response of Kalmegh Growth, Yield, and Quality
  3. Genetic Variability and Diversity in Red Onion Genotypes
  4. An Updated Review on Anticancer Efficacy of Melittin from Bee Venom
  5. Biological Activity of Cyclic Peptide from Sphaeranthus amaranthoides
  6. Cytotoxicity of Hydroxyl Functionalized MWCNT in Oral Squamous Carcinoma
  7. Immunomodulatory Role of CDK4/6 Inhibitors in Tumor Microenvironment
  8. Crosstalk Between Immunotherapy and Tumor Metabolism
  9. ACC Deaminase Produced by PGPR Mitigates Osmotic and Salinity Stresses
  10. Nanotechnology-Based Agrochemicals in Food Security and Sustainable Agriculture
  11. Biomedical and Antioxidant Potentialities in Chilli
  12. Identification of Novel Inhibitor of InhA Enzyme in Mycobacterium tuberculosis
  13. Therapeutic Role of Mesenchymal-Derived Stem Cells in COVID-19
  14. Metallic and Polyether Ionophores in Cancer Management
  15. Moringa oleifera: Miracle Plant with Medicinal Importance

Conclusion:

Dr. Tarun Kumar Upadhyay exemplifies what it means to be an outstanding researcher in the field of biotechnology. His impressive academic background, combined with an extensive research portfolio, outstanding teaching contributions, and mentorship of future scientists, makes him an ideal candidate for the Best Researcher Award. His work not only advances knowledge in biotechnological and pharmaceutical sciences but also holds immense potential for real-world applications in healthcare and agriculture.

His recognition in prestigious journals, his successful research grants, and the awards he has received speak volumes about his research’s depth and impact. Furthermore, his involvement in editorial roles and science policy highlights his leadership within the scientific community.

Considering his innovative research, dedication to teaching, academic leadership, and significant contributions to the scientific community, Dr. Upadhyay is more than deserving of the Best Researcher Award.

 

 

Steeven Louis | Cell Migration Studies | Best Researcher Award

Published on by Cell Biologist

Mr. Steeven Louis | Cell Migration Studies | Best Researcher Award

Mr. Steeven Louis  , Psy-DREPI LAB / Université de Bourgogne , France

Dr. Steeven Louis is a distinguished psychologist with a specialization in clinical psychology and psychopathology. He is currently a postdoctoral fellow at the University of Quebec in Montreal (UQAM) and a candidate for an adjunct professor position in Health Psychology at the University of Montreal. Dr. Louis holds a Ph.D. from the University of Burgundy, France, and has an extensive academic and professional background, including teaching roles at prestigious universities such as Paris Nanterre and the University of Bourgogne. He has been actively involved in research on complex trauma, resilience, and migration, particularly focused on the Haitian earthquake survivors. With multiple publications and a comprehensive research portfolio, Dr. Louis is dedicated to understanding the psychological impacts of migration and trauma while contributing significantly to the academic and clinical fields.

Publication Profile:

Orcid

Strengths for the Award:

Steeven LOUIS is an outstanding candidate for the Best Researcher Award due to his substantial academic background, innovative research, and broad teaching experience. His Ph.D. in Clinical Psychology and Psychopathology from the University of Burgundy focuses on a unique intersection of trauma, migration, and spirituality, specifically exploring the resilience of Haitian survivors of the 2010 earthquake. His work addresses significant global health issues, especially in understanding complex trauma and its socio-cultural implications. His contributions to the field are evident through his published articles and involvement in international research committees, demonstrating a robust capacity for both individual research and collaborative efforts. Additionally, his role in shaping future psychologists through his teaching positions highlights his dedication to academic excellence.

Areas for Improvement:

One potential area for growth is further diversification of his research into other forms of mental health crises, particularly in other cultural contexts beyond the Haitian diaspora. Expanding his research network to include interdisciplinary collaborations with public health professionals or policymakers could also increase the global impact of his work.

Education:

Dr. Steeven Louis completed his Ph.D. in Clinical Psychology and Psychopathology at the University of Burgundy, France, where his thesis focused on the role of spirituality in the resilience of Haitian earthquake survivors. He earned a Master’s in Clinical Psychology and Psychotherapy from the University of Paris 8, France, and another Master’s in Clinical Psychology and Psychotherapy. His Bachelor’s degree was from the University of Paris 8, France, and the Université d’État d’Haïti. Dr. Louis further pursued additional training in areas like ethical practice, consultation, and supervision, including a 45-hour training in “Consultation and Supervision” by the Ordre des Psychologues du Québec. His academic journey also includes specializations in methodologies, attachment theory, and trauma-focused research, laying the foundation for his outstanding contributions to the field of psychology. Dr. Louis is currently continuing his professional development through various advanced courses and training programs.

Experience:

Dr. Steeven Louis has an impressive academic and research career, with experience in both teaching and research at various universities. As a postdoctoral fellow at UQAM, he explores complex trauma and migration, focusing on the integration of recent immigrants in Quebec. Dr. Louis has taught and led research in clinical psychology and psychopathology at the University of Paris Nanterre and the University of Burgundy. His courses ranged from methodologies in qualitative research and clinical psychology to cognitive-behavioral therapies (CBT). Additionally, he has served as an ATER (temporary lecturer and researcher) at the University of Paris Nanterre, guiding students in clinical psychology and research methodologies. His roles also included mentoring students in their research, thesis supervision, and contributions to committees for thesis evaluations. Through his extensive teaching and mentorship experience, Dr. Louis has shaped the next generation of psychologists while advancing the field through his active involvement in scientific committees and conferences.

Research Focus:

Dr. Steeven Louis’ research primarily revolves around the psychological impacts of migration, trauma, and resilience, with a particular focus on Haitian survivors of the 2010 earthquake. His work explores the role of spirituality in resilience among disaster survivors, examining both the psychological and social aspects of trauma. Dr. Louis investigates complex trauma, particularly in migrants who have experienced both the trauma of natural disasters and the challenges of migration. His research also addresses how cultural and spiritual factors influence the coping mechanisms and resilience of affected individuals. This interdisciplinary approach, combining clinical psychology, migration studies, and spirituality, has led to valuable insights into the mental health of migrant populations. His ongoing research aims to bridge the gap between cultural practices, trauma recovery, and psychological interventions, making significant contributions to understanding the psychological needs of displaced and vulnerable populations.

Publications Top Notes:

  • Louis, S., & Derivois, D. (2024). “Religion et spiritualité chez une population haïtienne victime du séisme de 2010 en Haïti” 🧠🕊️
  • Louis, S., & Derivois, D. (2024). “Spirituality, depression and resilience: a quantitative study post-2010 earthquake in Haiti” 📊💡
  • Louis, S., & Derivois, D. (2024). “Complex trauma and traumatic migration abroad: the experience of double absence” 🌍🌀
  • Louis, S., & Derivois, D. (2024). “Les chefs religieux et spirituels comme tuteurs de résilience dans l’Haïti post-séisme” ⛪💪
  • Louis, S., & Derivois, D. (2024). “Vécu migratoire post-séisme chez les migrants haïtiens: une étude qualitative” ✈️🔍
  • Louis, S., & Derivois, D. (2024). “Spirituality, migration, and resilience in Haiti: a literature update” 📖🌱

Conclusion:

Dr. Steeven LOUIS exemplifies the qualities of a top-tier researcher. His dedication to understanding the intersection of trauma, spirituality, and migration, alongside his deep commitment to education, positions him as an exceptional candidate for this award. With his focused research and teaching record, Dr. LOUIS is poised to make even greater contributions to the field of psychology.

 

 

Huiying Fan | Host-Pathogen Interactions | Best Researcher Award

Published on by Cell Biologist

Dr. Huiying Fan | Host-Pathogen Interactions | Best Researcher Award

Dr. Huiying Fan , College of Veterinary Medicine, South China Agricultural University , China

Dr. Huiying Fan is a distinguished professor and doctoral supervisor at the College of Veterinary Medicine, South China Agricultural University, specializing in veterinary virology and immunology. As a core member of the Key Laboratory for Veterinary Vaccine Development, his expertise includes creating genetically engineered vaccines for animal viruses. Dr. Fan has published over 40 research papers in leading journals, including Journal of Virology and Emerging Microbes & Infections, and holds 11 invention patents. His career has been marked by significant contributions to animal virus research and vaccine development, with extensive involvement in national research programs. He has been recognized with several provincial and ministerial-level awards and is actively involved in scientific development and industry collaboration in China.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Huiying Fan has demonstrated exceptional contributions to the field of veterinary virology and immunology, particularly in the development of vaccines for animal viruses. He is a recognized leader in the creation of genetically engineered vaccines, with over 40 SCI papers published in high-impact journals such as Journal of Virology, Emerging Microbes & Infection, and Vaccines. His involvement in groundbreaking research on the pathogenic mechanisms of viruses like avian influenza, porcine epidemic diarrhea, and African swine fever underscores his expertise. Furthermore, Dr. Fan has been granted 11 invention patents and is an influential figure in national research programs, such as the National Key Research and Development Program. His leadership as a professor and mentor, coupled with his ongoing innovations in virus detection and vaccine development, showcases his remarkable impact in the field.

Areas for Improvement:

While Dr. Fan’s scientific research has been groundbreaking, expanding his focus on broader global collaborations could enhance the scope of his work. In particular, his work could benefit from incorporating more interdisciplinary approaches, combining cutting-edge technologies such as artificial intelligence or big data analytics, which are becoming increasingly crucial in disease surveillance and vaccine development. Moreover, his research could further address the application of his vaccine technologies in low-resource settings, to maximize global health impact. Engaging more actively in science communication could also help translate his findings into policies or programs that benefit larger populations, both within China and internationally.

Education:

Dr. Fan completed his Ph.D. in Preventive Veterinary Medicine at the College of Veterinary Medicine, Huazhong Agricultural University, in June 2007. During his doctoral research, he focused on the study of veterinary diseases and virus-host interactions, laying a strong foundation for his future work in vaccine development. His commitment to advancing veterinary science continued through postdoctoral training, followed by his establishment as a professor at South China Agricultural University. His education reflects his dedication to merging academic research with practical applications for the improvement of animal health and disease prevention.

Experience:

Dr. Fan’s career began in 2007 as a professor at South China Agricultural University, where he became a leading figure in veterinary medicine. He has also contributed significantly to international research, evidenced by his six-month research visit to City University of Hong Kong in 2016. As a core member of several high-impact research initiatives, including the National Key Research and Development Program, he has played a vital role in advancing veterinary virology and vaccine development. Dr. Fan’s extensive expertise has led to collaborations across national projects and scientific endeavors, particularly in the realm of infectious diseases and immune responses in animals.

Awards and Honors:

Dr. Fan has received multiple prestigious awards throughout his career, including 8 provincial and ministerial-level honors. Notably, he was named a “Pearl River Science and Technology Star” in Guangzhou and recognized as a “Science and Technology Commissioner” by the People’s Government of Guangdong Province. His contributions to veterinary science have garnered recognition both within China and internationally, highlighting his commitment to scientific excellence and industry collaboration. These accolades underscore his leadership in veterinary vaccine research and his influence on public health initiatives concerning animal diseases.

Research Focus:

Dr. Fan’s primary research interests lie in the molecular design of genetically engineered vaccines for animal viruses, including those affecting poultry and swine. His studies explore the immune mechanisms and pathogenesis of viruses such as avian influenza and porcine viral diarrhea. In addition to his work on vaccine development, he investigates the use of innovative techniques, including CRISPR/Cas12a and proteomics, to better understand virus-host interactions and to improve diagnostic and therapeutic strategies for animal diseases. His focus on veterinary virology aims to enhance both animal and public health outcomes.

Publication Top Notes:

  1. “A single immunization with H5N1 virus-like particle vaccine protects chickens against divergent H5N1 influenza viruses” 🐔🦠
  2. “Influenza H7N9 Virus Hemagglutinin with T169A Mutation Possesses Enhanced Thermostability” 🦠❄️
  3. “Immune Escape Mechanism and Vaccine Research Progress of African Swine Fever Virus” 🐖🦠
  4. “Supplementation of H7N9 Virus-Like Particle Vaccine With Recombinant Epitope Antigen Confers Full Protection” 🦠💉
  5. “PEDV infection affects the expression of polyamine-related genes inhibiting viral proliferation” 🐖🧬
  6. “Proteome Analysis in PAM Cells Reveals That African Swine Fever Virus Can Regulate Intracellular Polyamines” 🧬🔬
  7. “CRISPR/Cas12a Technology Combined with Immunochromatographic Strips for Portable Detection of ASF Virus” 🧬🦠
  8. “Quantitative Proteomics Reveals Changes in Vero Cells in Response to Porcine Epidemic Diarrhea Virus” 🐖🔬
  9. “Coimmunization with recombinant epitope-expressing baculovirus enhances protective effects of H5N1 vaccine” 💉🦠
  10. “Either fadD1 or fadD2, Which Encode acyl-CoA Synthetase, Is Essential for the Survival of Haemophilus parasuis SC096” 🦠🔬
  11. “Two Glycosyltransferase Genes of Haemophilus parasuis SC096 Implicated in Lipooligosaccharide Biosynthesis” 🧬🦠
  12. “Recombinant baculovirus vaccine containing multiple M2e and adjuvant LT induces T cell-dependent protection against H5N1” 💉🦠
  13. “BacMam virus-based surface display of IBV S1 glycoprotein confers strong protection against virulent IBV challenge” 🐔🦠
  14. “Quantitative Proteomics by Amino Acid Labeling in Foot-and-Mouth Disease Virus-Infected Cells” 🐄🧬
  15. “Quantitative proteomics using SILAC reveals protein and pathway regulation in porcine circovirus type 2 infected PK-15 cells” 🐖🧬

Conclusion:

Dr. Huiying Fan is undoubtedly a strong contender for the Research for Best Researcher Award, given his outstanding contributions to animal virus research, innovative vaccine design, and leadership in national research initiatives. His extensive publication record, patent portfolio, and recognition through prestigious awards highlight his scientific excellence. Although expanding his collaborative network and exploring interdisciplinary methodologies could elevate his impact further, Dr. Fan’s work has already had a profound effect on veterinary medicine and public health, making him a well-deserved nominee for this award.

 

 

Pawanpreet Singh | Pharmacy | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Pawanpreet Singh | Pharmacy | Best Researcher Award

Assoc. Prof. Dr. Pawanpreet Singh , RIMT University , India

Dr. Pawanpreet Singh is an accomplished academic and researcher in the field of Pharmaceutical and Medicinal Chemistry. He currently serves as an Associate Professor at RIMT University, Punjab, with a focus on Crystal Engineering, Polymorphism, Co-crystallization, and Pharmaceutical Solids Modification. With over a decade of experience in teaching and research, he has contributed to various scientific advancements, particularly in pharmaceutical solid dosage forms. Dr. Singh has worked as a Postdoctoral Fellow at Dr. Reddy’s Laboratories and as a UGC-Research Fellow at Panjab University. He has also presented at international conferences and has been a part of significant research projects in pharmaceutical sciences. His expertise in computational modelling, crystallography, and formulation R&D is highly regarded, and he is a dedicated educator and mentor in the field.

Publication Profile:

Scopus

Strengths for the Award:

  1. Extensive Academic Background: Dr. Pawanpreet Singh has an impressive academic record, holding a Ph.D. in Pharmaceutical Chemistry and M.Pharm. with distinction. His research work is extensive and covers key areas in pharmaceutical and medicinal chemistry, including crystal engineering, polymorphism, and co-crystallization.
  2. Diverse Research Experience: Dr. Singh has significant research experience across various esteemed institutions, including RIMT University, Panjab University, and I.K. Gujral Punjab Technical University. His research areas, including pharmaceutical solids modification and clinical research, demonstrate his broad expertise.
  3. Postdoctoral and Industry Experience: His postdoctoral work at Dr. Reddy’s Laboratories, focusing on formulation R&D and quality improvement programs, shows practical industry application and hands-on experience in improving pharmaceutical processes, which further strengthens his credentials.
  4. Innovation and Publications: Dr. Singh has contributed several high-impact research papers in reputable journals, many of which are focused on crystal engineering and pharmaceutical development. His work on polymorph prediction and crystal structure determination has the potential to significantly impact drug design and development.
  5. Awards and Recognition: His consistent achievements, including an international travel award and recognition for his poster presentations at prestigious global conferences, highlight his reputation in the research community.
  6. Patents and Book Publications: Dr. Singh has been granted a patent for “Novel cocrystals of aceclofenac with improved bioavailability,” which showcases his innovation and contribution to pharmaceutical sciences. He has also authored books on medicinal chemistry and drug development.
  7. Hands-On Skills and Workshops: His active participation in various hands-on workshops, such as those on X-ray diffraction, chromatography, and crystallography, reflects his continuous effort to upgrade his technical skills.
  8. Leadership and Contribution to Academic Development: Dr. Singh’s role as a faculty member, his leadership as a class representative, and his involvement in various academic events demonstrate his leadership skills and commitment to educational advancement.

Areas for Improvement:

  1. Broader Interdisciplinary Collaboration: While Dr. Singh’s expertise in pharmaceutical chemistry is remarkable, expanding his research into more interdisciplinary domains, such as nanotechnology, biotechnology, and personalized medicine, could open new frontiers in his research career. Collaborating with experts from other fields could enhance the scope and impact of his work.
  2. Increased Research Visibility: Although Dr. Singh has made substantial contributions through publications and presentations, he could further enhance the visibility of his work by focusing on publishing in higher-impact journals or in interdisciplinary fields, where his work could influence broader scientific communities.
  3. Mentorship and Supervision: Given his considerable academic background, taking a more active role in mentoring Ph.D. and postdoctoral researchers could further contribute to the academic and research community. Increased focus on guiding future researchers would build a legacy of innovation and research excellence.
  4. Expanding International Collaborations: Although Dr. Singh has attended international conferences and presented posters globally, strengthening long-term international research collaborations could lead to more groundbreaking and globally impactful research projects.

Education:

Dr. Pawanpreet Singh completed his PhD in Pharmaceutical Sciences from the University Institute of Pharmaceutical Sciences, Panjab University, in 2018, under the supervision of Prof. Renu Chadha. His doctoral research focused on Crystal Engineering and Protein Binding Studies for antibacterial agents. Prior to this, he earned his Master’s in Pharmacy (M.Pharm) from G.H.G Khalsa College of Pharmacy in 2010, specializing in Pharmaceutical Chemistry with distinction. His undergraduate studies (B.Pharm) were completed at the same institution, where he achieved a first division. Dr. Singh also completed his secondary education at SCD Government College for Boys, Ludhiana, securing top positions. His strong academic foundation is further supported by certifications in specialized areas such as FTIR, HPLC, and X-ray diffraction, contributing to his expertise in medicinal chemistry and pharmaceutical research.

Experience:

Dr. Pawanpreet Singh has a rich academic and industrial experience spanning over a decade. He currently serves as an Associate Professor at RIMT University, Punjab, since February 2023, focusing on Pharmaceutical and Medicinal Chemistry. Prior to this role, he was an Assistant Professor at RIMT University, College of Pharmacy (September 2022 – February 2023) and at I.K. Gujral Punjab Technical University (November 2020 – June 2022). Dr. Singh has significant industrial exposure as a Postdoctoral Fellow at Dr. Reddy’s Laboratories (2017-2020), where he worked on Formulation R&D, technology transfer, and quality improvement. His research contributions are further backed by his work as a UGC-Research Fellow at Panjab University (2012-2017), under the guidance of Prof. Renu Chadha. With expertise in crystallography, formulation science, and computational modelling, he has developed several pharmaceutical products and processes, enhancing his academic and practical approach in research and teaching.

Awards and Honors:

Dr. Pawanpreet Singh has received numerous awards and honors throughout his career. He was awarded the prestigious UGC-Research Fellowship in Science for Meritorious Students (RFSMS) in 2012 for his outstanding academic performance. Dr. Singh also received the International Travel Award from the Department of Biotechnology, Government of India, to attend the ASM Microbe 2016 conference in Boston, USA. He won the First Prize in a poster presentation at the 10th National Conference on Thermodynamics of Pharmaceutical, Chemical, and Biological Systems in 2015. Additionally, he was recognized for his leadership as the Class Representative of PhD scholars at UIPS, Panjab University (2015-16). Dr. Singh’s research excellence is highlighted by his numerous publications in high-impact journals, and his contribution to the scientific community through his innovative work in pharmaceutical research. His achievements further underline his dedication to advancing pharmaceutical sciences and education.

Research Focus:

Dr. Pawanpreet Singh’s research interests are centered around Pharmaceutical and Medicinal Chemistry, with a particular focus on crystal engineering, polymorphism, and co-crystallization. His work aims to improve the physicochemical properties of pharmaceutical solid dosage forms, including their solubility, bioavailability, and stability. Dr. Singh has extensive experience in the preparation, characterization, and biological evaluation of various pharmaceutical solids, including polymorphs, co-crystals, and eutectics. His research integrates experimental and computational techniques, utilizing tools like CASTEP, Crystal Solve, and molecular docking to predict and characterize crystal structures. He has worked extensively on pharmaceutical polymorph screening and the design of solid forms with enhanced performance. Additionally, Dr. Singh is involved in formulating strategies for drug delivery and developing new methodologies for enhancing the stability and effectiveness of pharmaceutical compounds. His contributions to pharmaceutical solids modification have the potential to lead to more effective treatments with improved pharmacological properties.

Publications Top Notes:

  1. Structural and biopharmaceutical evaluation of newly synthesized norfloxacin co-crystals using crystal engineering approach, Journal of Molecular Structure, 2023 🧑‍🔬💊
  2. Depicting polymorphism in eutectic mixtures, DOI: 10.21203/rs.3.rs-1708945/v1 🔬📑
  3. A new polymorph of ciprofloxacin saccharinate: Structural characterization and pharmaceutical profile, Journal of Pharmaceutical and Biomedical Analysis, 2017 💊🔍
  4. Crystal structure prediction in the context of pharmaceutical polymorph screening and putative polymorphs of ciprofloxacin, International Journal of Pharmacy and Pharmaceutical Sciences, 2017 🔬💊
  5. Ciprofloxacin Hippurate Salt: Crystallization Tactics, Structural Aspects, and Biopharmaceutical Performance, Crystal Growth & Design, 2016 💊🧪
  6. Report on the Sixth Blind Test of Organic Crystal-Structure Prediction Methods, Acta Crystallographica Section B, 2016 🧑‍🔬📑
  7. New conformational polymorph of Hydrochlorothiazide with improved solubility, Pharmaceutical Development and Technology, 2015 💧💊
  8. Molecular Docking: A challenged and effectual approach, The Pharmacos, 2014 💻🔬
  9. Synthesis and thin layer chromatography of some new D-homo azasteroidal compounds, International Journal of Current Research and Review, 2011 🔬📄

Conclusion:

Dr. Pawanpreet Singh is highly deserving of the Best Researcher Award due to his deep expertise in pharmaceutical sciences, particularly in crystal engineering, polymorphism, and solid dosage form modification. His academic accomplishments, industrial experience, and significant contributions through research papers and patents make him an exemplary candidate. With continued interdisciplinary collaboration and greater international research visibility, Dr. Singh has the potential to further elevate his impact in the field. His track record of innovative research, mentorship, and leadership in academic settings highlights his commitment to advancing pharmaceutical sciences.